- 19% growth in annual revenue to $289.3
million
- 39% growth in annual Adjusted EBITDA1 to a record
$53.3 million
- Annual Adjusted gross margin percentage1 of
31.6%
- Backlog1 of $252.8
million, representing 326 days of annualized revenue, as at
December 31, 2024
- Increases 2025 Adjusted EBITDA guidance to a range of
$55 to $60
million
MONTREAL, Feb. 25,
2025 /CNW/ - 5N Plus Inc. (TSX:
VNP) ("5N+" or "the Company"), a leading
global producer of specialty semiconductors and performance
materials, today announced its financial results for the fourth
quarter of fiscal 2024 ("Q4 2024") and fiscal year ("FY
2024") ended December 31, 2024. All amounts in this press
release are expressed in U.S. dollars unless otherwise stated.

"We had an outstanding year in FY 2024, generating stellar
financial and operational results. We generated record annual
Adjusted EBITDA representing 39% growth over the previous year,
delivered on our margin expansion efforts, and sustained an
elevated backlog and a solid balance sheet. We also successfully
increased capacity at several sites to meet demand in strategic
sectors, with work underway to increase solar cell capacity at AZUR
by an additional 30% this year, on top of the 35% achieved last
year. Looking at our segments, in Specialty Semiconductors, we
continued to benefit from our unique position as the leading
supplier outside China and trusted
partner in the growing terrestrial renewable energy and space solar
power sectors. In Performance Materials, our improved product mix
and solid operational execution also contributed to strong
profitability," said Gervais Jacques, President and CEO of
5N+.
"Our strategic focus on higher margin, value-added advanced
materials and on being a critical supplier without being a critical
cost to customers operating in growing markets continues to pay
off. This is further supported by our recognition as a reliable
partner and market leader with unique expertise and manufacturing
capabilities. With our resilient and agile business model as our
foundation, we will continue to leverage our strategic positioning
and competitive advantages to build on our FY 2024 momentum as we
enter 2025 and forge ahead on our profitable growth path,"
concluded Mr. Jacques.
Financial Highlights
- Revenue in Q4 2024 increased by 9% to $70.9 million, compared to $65.1 million in Q4 2023, driven by strong growth
under Specialty Semiconductors. Revenue in FY 2024 reached
$289.3 million, compared to
$242.4 million in FY 2023, supported
by the terrestrial renewable energy and space solar power sectors
under Specialty Semiconductors.
- Adjusted EBITDA in Q4 2024 increased by 38% to $12.5 million, compared to $9.0 million in Q4 2023, driven by higher volume
from the terrestrial renewable energy and space solar power
sectors, and better prices over inflation. Adjusted EBITDA was
$53.3 million in FY 2024,
representing a 39% increase compared to $38.3 million in FY 2023.
- Adjusted gross margin1 increased by 26% to
$23.4 million in Q4 2024, favourably
impacted by the same factors as above. Adjusted gross margin as a
percentage of sales was 33.0% in Q4 2024, compared to 28.5% in Q4
2023. Adjusted gross margin reached $91.3
million for FY 2024, or 31.6% of sales, compared to
$70.2 million in FY 2023, or 29.0% of
sales.
- Net earnings in Q4 2024 were $1.0
million, compared to $2.3
million in Q4 2023. For FY 2024, net earnings were
$14.7 million, compared to
$15.4 million in FY 2023.
- Backlog stood at $252.8 million,
representing 326 days of annualized revenue as at December 31, 2024, 37 days higher than the
previous quarter and 34 days higher than at the end of last year,
primarily due to the timing of contract signings and renewals.
- Net debt1 was $100.1
million as at December 31,
2024, compared to $73.8
million as at December 31,
2023, reflecting an increase in working capital1
and planned capital expenditures in 2024 under Specialty
Semiconductors. The Company's net debt to EBITDA ratio1
stood at 2.02x as at December 31,
2024.
____________________________
|
1 These
measures are not recognized measures under IFRS and do not have
standardized meanings prescribed by IFRS and therefore may not be
comparable to similar measures presented by other companies. See
Non-IFRS Measures for more information.
|
Market Outlook
In Specialty Semiconductors, 5N+ continues to benefit from its
unique position as the leading global supplier of ultra-high purity
semiconductor compounds outside China, with long-term partnerships with key
customers. Growing demand remains the rule, particularly in
terrestrial renewable energy and space solar power. 5N+ is
well-positioned to capitalize on future opportunities in these
high-growth sectors.
The Company also anticipates growth under imaging and sensing
applications including in the security, defence and medical
sectors. The anticipated transition to photon counting detector
(PCD) technology for medical imaging is anticipated to provide a
promising growth avenue in the medium term.
Management expects growth in the Performance Materials segment
to be primarily driven by the health and pharmaceutical sector,
which provides high profitability and predictable cashflows. We
expect demand for bismuth chemicals to continue to grow in line
with GDP in respective markets.
As a result of increased production capacity and operational
flexibility, 5N+ is in a position to efficiently capture additional
organic growth opportunities in the near term, while it also
actively pursues external growth opportunities.
Based on under-contract and anticipated near-term demand
primarily driven by the Specialty Semiconductors segment,
management anticipates generating Adjusted EBITDA in a range of
$55 to $60
million in 2025, representing an upward revision of its
previously disclosed range of $50 to
$55 million.
The recent change in administration in the U.S. creates
uncertainty in the global economic outlook, particularly regarding
potential trade protectionist measures that could trigger
retaliatory actions from affected countries. Given the rapidly
evolving landscape and the potential impact of these measures, the
Company has elected to defer providing guidance for 2026 until it
has had the opportunity to further assess the direct and indirect
impacts on its business and operations. The Company remains
committed to its long-term objectives and the execution of its
strategic initiatives.
The Company intends to leverage its strategic positioning and
competitive advantages to build on its FY 2024 momentum as it
enters 2025 and to navigate any potential headwinds that result
from the evolving macro-economic and geopolitical environment.
Conference Call
5N+ will host a conference call
on Wednesday, February 26, 2025, at 8:00 a.m. Eastern Time
to discuss Q4 and FY 2024 financial results. All
interested parties are invited to participate in the live broadcast on the
Company's website at www.5nplus.com.
To participate in the conference call:
- Toronto area:
289-819-1299
- Toll‐Free: 1-800-990-4777
- Enter access code: 71321
A replay of the conference call will be available two hours
after the event and until March 5, 2025. To access the
recording, please dial 1-888-660-6345 and enter access
code 71321.
________________________________
|
1
These measures are not recognized measures under IFRS and do not
have standardized meanings prescribed by IFRS and therefore may not
be comparable to similar measures presented by other companies. See
Non-IFRS Measures for more information.
|
About 5N+
5N+ is a leading global producer of specialty semiconductors and
performance materials. The Company's ultra‐pure materials often
form the core element of its customers' products. These customers
rely on 5N+'s products to enable performance and sustainability in
their own products. 5N+ deploys a range of proprietary and proven
technologies to develop and manufacture its products. The Company's
products enable various applications in several key industries,
including renewable energy, security, space, pharmaceutical,
medical imaging and industrial. Headquartered in Montréal,
Quebec, 5N+ operates R&D,
manufacturing and commercial centers in strategically located
facilities around the world including Europe, North
America and Asia.
Forward‐Looking Statements
Certain statements in this press release may be forward‐looking
within the meaning of applicable securities laws. Such
forward‐looking statements are based on a number of estimates and
assumptions that the Company believes are reasonable when made,
including that 5N+ will be able to retain and hire key personnel
and maintain relationships with customers, suppliers and other
business partners, that 5N+ will continue to operate its business
in the normal course, that 5N+ will be able to implement its growth
strategy, that 5N+ will be able to successfully and timely complete
the realization of its backlog, that 5N+ will not suffer any supply
chain challenges or any material disruption in the supply of raw
materials on competitive terms, that 5N+ will be able to generate
new sales, produce, deliver, and sell its expected product volumes
at the expected prices and control its costs, as well as other
factors believed to be appropriate and reasonable in the
circumstances. However, there can be no assurance that such
estimates and assumptions will prove to be correct. These
statements are not guarantees of future performance and involve
assumptions, risks and uncertainties that are difficult to predict
and may cause the Company's actual results, performance or
achievements to be materially different from any future results,
performance or achievements expressed or implied by such
forward‐looking statements. A description of the risks affecting
the Company's business and activities appears under the heading
"Risk and Uncertainties" of the Company's 2024 MD&A dated
February 25, 2025, available on www.sedarplus.ca.
Forward‐looking statements can generally be identified by the
use of terms such as "may", "should", "would", "believe", "expect",
the negative of these terms, variations of them or any similar
terms. No assurance can be given that any events anticipated by the
forward‐looking statements in this press release will transpire or
occur, or if any of them do so, what benefits that 5N+ will derive
therefrom. In particular, no assurance can be given as to the
future financial performance of 5N+. The forward‐looking statements
contained in this press release is made as of the date hereof and
the Company has no obligation to publicly update such
forward‐looking information to reflect new information, subsequent
or otherwise, unless required by applicable securities laws. The
reader is warned against placing undue reliance on these
forward‐looking statements. Forward-looking statements are
presented in this press release for the purpose of assisting
investors and others in understanding certain key elements of the
Company's expected financial results, as well as the Company's
objectives, strategic priorities and outlook, and in obtaining a
better understanding of the Company's anticipated operating
environment. Readers are cautioned that such information may not be
appropriate for other purposes.
5N PLUS INC.
CONSOLIDATED STATEMENTS OF EARNINGS
Years ended December 31
(in thousands of United States
dollars, except per share information)
|
|
2024
|
2023
|
|
|
$
|
$
|
Revenue
|
|
289,281
|
242,371
|
Cost of
sales
|
|
211,413
|
184,833
|
Selling, general and
administrative expenses
|
|
34,026
|
29,410
|
Other expenses
(income), net
|
|
11,614
|
756
|
|
|
257,053
|
214,999
|
Operating
earnings
|
|
32,228
|
27,372
|
|
|
|
|
Financial
expenses
|
|
|
|
Interest on long-term
debt
|
|
8,210
|
8,262
|
Imputed interest and
other interest expense
|
|
959
|
572
|
Foreign exchange
gain
|
|
(549)
|
(136)
|
|
|
8,620
|
8,698
|
Earnings before
income taxes
|
|
23,608
|
18,674
|
Income tax expense
(recovery)
|
|
|
|
Current
|
|
6,945
|
6,674
|
Deferred
|
|
1,991
|
(3,399)
|
|
|
8,936
|
3,275
|
Net
earnings
|
|
14,672
|
15,399
|
|
|
|
|
Basic earnings per
share
|
|
0.17
|
0.17
|
Diluted earnings per
share
|
|
0.16
|
0.17
|
Net earnings are
completely attributable to equity holders of 5N+.
|
5N PLUS INC.
CONSOLIDATED STATEMENTS OF FINANCIAL
POSITION
(in thousands of United States
dollars)
|
|
December
31
2024
|
December 31
2023
|
|
|
$
|
$
|
Assets
|
|
|
|
Current
|
|
|
|
Cash
|
|
22,142
|
34,706
|
Accounts
receivable
|
|
42,172
|
33,437
|
Inventories
|
|
137,823
|
105,850
|
Income tax
receivable
|
|
1,811
|
1,672
|
Derivative financial
assets
|
|
6,978
|
591
|
Other current
assets
|
|
6,469
|
5,707
|
Total current
assets
|
|
217,395
|
181,963
|
Property, plant and
equipment
|
|
85,995
|
84,600
|
Right-of-use
assets
|
|
28,583
|
29,290
|
Intangible
assets
|
|
22,929
|
29,304
|
Goodwill
|
|
10,665
|
11,825
|
Deferred tax
assets
|
|
7,358
|
8,261
|
Other assets
|
|
3,982
|
4,959
|
Total non-current
assets
|
|
159,512
|
168,239
|
Total
assets
|
|
376,907
|
350,202
|
|
|
|
|
Liabilities
|
|
|
|
Current
|
|
|
|
Trade and accrued
liabilities
|
|
42,116
|
37,024
|
Income tax
payable
|
|
5,207
|
4,535
|
Current portion of
deferred revenue
|
|
11,206
|
13,437
|
Current portion of
lease liabilities
|
|
1,952
|
1,811
|
Current portion of
long-term debt
|
|
-
|
25,000
|
Total current
liabilities
|
|
60,481
|
81,807
|
Long-term
debt
|
|
122,203
|
83,500
|
Deferred tax
liabilities
|
|
5,737
|
5,284
|
Employee benefit plan
obligations
|
|
12,624
|
13,393
|
Lease
liabilities
|
|
27,450
|
28,328
|
Deferred
revenue
|
|
8,688
|
5,629
|
Other
liabilities
|
|
706
|
3,669
|
Total non-current
liabilities
|
|
177,408
|
139,803
|
Total
liabilities
|
|
237,889
|
221,610
|
|
|
|
|
Equity
|
|
139,018
|
128,592
|
Total liabilities
and equity
|
|
376,907
|
350,202
|
|
|
|
|
|
|
|
|
|
|
|
|
Non‐IFRS Measures
EBITDA means net earnings (loss) before interest expenses,
income tax expense (recovery), depreciation and amortization. 5N+
uses EBITDA because it believes it is a meaningful measure of the
operating performance of its ongoing business, without the effects
of certain expenses. The definition of this non-IFRS measure used
by the Company may differ from that used by other companies.
EBITDA is reconciled to the most comparable IFRS measure:
(in thousands of U.S.
dollars)
|
Q4
2024
|
Q4 2023
|
FY
2024
|
FY 2023
|
|
$
|
$
|
$
|
$
|
Net earnings
|
1,006
|
2,284
|
14,672
|
15,399
|
Interest on long-term
debt, imputed interest and other interest expense
|
2,446
|
2,129
|
9,169
|
8,834
|
Income tax expense
(recovery)
|
2,415
|
(734)
|
8,936
|
3,275
|
Depreciation and
amortization
|
4,373
|
4,057
|
16,791
|
16,110
|
EBITDA
|
10,240
|
7,736
|
49,568
|
43,618
|
EBITDA margin is defined as EBITDA divided by revenues.
Adjusted EBITDA means operating earnings (loss) as defined
before the effect of impairment of inventories, share-based
compensation expense (recovery), loss (gain) on disposal of
property, plant and equipment, loss (gain) on remeasurement of
financial instrument, impairment (reversal of impairment) of
non-current assets, litigation and restructuring costs (income),
and depreciation and amortization. 5N+ uses Adjusted EBITDA because
it believes it is a meaningful measure of the operating performance
of its ongoing business without the effects of certain expenses.
The definition of this non-IFRS measure used by the Company may
differ from that used by other companies.
Adjusted EBITDA margin is defined as Adjusted EBITDA divided by
revenues.
Adjusted EBITDA and Adjusted EBITDA margin are reconciled to the
most comparable IFRS measure:
(in thousands of U.S.
dollars)
|
Q4
2024
|
Q4 2023
|
FY
2024
|
FY 2023
|
|
$
|
$
|
$
|
$
|
Revenues
|
70,854
|
65,063
|
289,281
|
242,371
|
Operating
expenses
|
(64,701)
|
(61,023)
|
(257,053)
|
(214,999)
|
Operating
earnings
|
6,153
|
4,040
|
32,228
|
27,372
|
Share-based
compensation expense
|
309
|
414
|
906
|
1,432
|
(Gain) loss on disposal
of property, plant and equipment
|
-
|
-
|
(2,089)
|
1,051
|
Loss on remeasurement
of financial instrument
|
1,000
|
-
|
1,000
|
-
|
(Reversal of
impairment) impairment of non-current assets
|
(120)
|
64
|
2,706
|
672
|
Litigation and
restructuring costs (income)
|
769
|
458
|
1,790
|
(8,314)
|
Depreciation and
amortization
|
4,373
|
4,057
|
16,791
|
16,110
|
Adjusted
EBITDA
|
12,484
|
9,033
|
53,332
|
38,323
|
Adjusted EBITDA
margin
|
17.6 %
|
13.9 %
|
18.4 %
|
15.8 %
|
Adjusted gross margin is a measure used to monitor the sales
contribution after paying cost of sales, excluding depreciation and
inventory impairment charges. 5N+ also expressed this measure in
percentage of revenues by dividing the adjusted gross margin value
by the total revenue.
Adjusted gross margin is reconciled to the most comparable IFRS
measure:
(in thousands of U.S.
dollars)
|
Q4
2024
|
Q4 2023
|
FY
2024
|
FY 2023
|
|
$
|
$
|
$
|
$
|
Total
revenue
|
70,854
|
65,063
|
289,281
|
242,371
|
Cost of
sales
|
(51,104)
|
(49,677)
|
(211,413)
|
(184,833)
|
Gross
margin
|
19,750
|
15,386
|
77,868
|
57,538
|
Depreciation included
in cost of sales
|
3,643
|
3,189
|
13,445
|
12,656
|
Adjusted gross
margin
|
23,393
|
18,575
|
91,313
|
70,194
|
Adjusted gross
margin percentage
|
33.0 %
|
28.5 %
|
31.6 %
|
29.0 %
|
Backlog represents the expected orders the Company has received,
but has not yet executed, and that are expected to translate into
sales within the next twelve months, expressed in dollars and
estimated in number of days not to exceed 365 days. Bookings
represent orders received during the period considered, expressed
in number of days, and calculated by adding revenues to the
increase or decrease in backlog for the period considered, divided
by annualized year revenues. 5N+ uses backlog to provide an
indication of expected future revenues in days, and bookings to
determine its ability to sustain and increase its revenues.
Net debt is calculated as total debt less cash. Any introduced
IFRS 16 reporting measures in reference to lease liabilities
are excluded from the calculation. 5N+ uses this measure as an
indicator of its overall financial position.
The net debt to EBITDA ratio is defined as net debt divided by
the trailing 12 months EBITDA.
Total debt and Net debt are reconciled to the most comparable
IFRS measure:
(in thousands of U.S.
dollars)
|
As at December 31,
2024
|
As at December 31,
2023
|
|
$
|
$
|
Bank
indebtedness
|
-
|
-
|
Long-term debt
including current portion
|
122,203
|
108,500
|
Lease liabilities
including current portion
|
29,402
|
30,139
|
Subtotal
Debt
|
151,605
|
138,639
|
Lease liabilities
including current portion
|
(29,402)
|
(30,139)
|
Total
Debt
|
122,203
|
108,500
|
Cash
|
(22,142)
|
(34,706)
|
Net
Debt
|
100,061
|
73,794
|
Working capital is a measure of liquid assets that is calculated
by taking current assets and subtracting current liabilities. Given
that the Company is currently indebted, it uses it as an indicator
of its financial efficiency and aims to maintain it at the lowest
possible level.
Working capital ratio is calculated by dividing current assets
by current liabilities.
Working capital is reconciled to the most comparable IFRS
measure:
(in thousands of U.S.
dollars)
|
As at December 31,
2024
|
As at December 31,
2023
|
|
$
|
$
|
Inventories
|
137,823
|
105,850
|
Other current assets
excluding inventories
|
79,572
|
76,113
|
Current
assets
|
217,395
|
181,963
|
Current
liabilities
|
(60,481)
|
(81,807)
|
Working
capital
|
156,914
|
100,156
|
Working capital
ratio
|
3.59
|
2.22
|
SOURCE 5N Plus Inc.